Dynamics of peritoneal transport and cardiovascular outcomes of peritoneal dialysis treatment

Abstract

BACKGROUND: Solute and water transport by peritoneal membrane has significant variation between patients; the function changes significantly over time. This affects treatment outcomes and requires individual approaches.

AIM: To evaluate the influence of the baseline peritoneal transport state, its dynamics during peritoneal dialysis and the possibility of long-term outcomes modification.

MATERIALS AND METHODS: The dynamics of peritoneal transport of solutes (in peritoneal equilibrium test, PET) and water (in mini-PET) was evaluated in a prospective interventional open-label study with historical control among 96 unselected consecutive patients admitted in three dialysis centers with unified program of peritoneal membrane monitoring and protection.

RESULTS: Compared to the matched standard arm, the increase in peritoneal solute transport was significantly slower (by 9.5%) in the observation group. Ultrafiltration in classical PET decreased more slowly (by 28%). At baseline ultrafiltration was satisfactory (the proportion of the patients with ultrafiltration less 400 ml was 7.6%); water transport by small pores did not decrease (−1.1 ± 5.9 ml/year), and the decrease in total ultrafiltration (by 32.1 ± 8.2 ml/year) was due to a decrease in free water transport (by 29.9 ± 7.6 ml/year). Negative dynamics of free water transport was associated with total glucose load and with monthly glucose load greater than 2.68 kg/month. More than one case of peritonitis was associated with a more rapid decline in free water transport. The comorbidity increased in 34 of 96 patients, with median first/last scores of 5 (4–6) and 6 (4–7) points; (Wilcoxon Z = −5.423; p < 0.001). When analyzed separately by peritoneal transport category, a significant worsening of the comorbidity index was observed only for high average and high transporters (Z = −2.754, p = 0.006 and Z = −3.357, p = 0.001, respectively).

CONCLUSIONS: The interaction between peritoneal transport, primarily free water transport, and cardiovascular disease is certainly two-way: deterioration of water balance due to loss of effective ultrafiltration leads to volume overload and progression of cardiovascular disease. On the other hand, cardiovascular disease contributes to peritoneal membrane damage. The most sensitive monitoring of interventions effectiveness in membrane protection and preventing cardiovascular disease progression is the separate measuring of water transport through small pores and ultrapores, which simultaneously reveals a feature of progressive peritoneal fibrosis, a potential precursor of encapsulating peritoneal sclerosis.

Keywords

peritoneal dialysis / peritoneal equilibration test / mini-PET

References

[1] Nolph KD, Hano JE, Teschan PE. Peritoneal sodium transport during hypertonic peritoneal dialysis. Ann Intern Med. 1969;70(5):931–941. doi: 10.7326/0003-4819-70-5-931

[2] Nolph K.D., Hano J.E., Teschan P.E. Peritoneal sodium transport during hypertonic peritoneal dialysis // Ann Intern Med. 1969. Vol. 70, N 5. P. 931–941. doi: 10.7326/0003-4819-70-5-931

[3] Morelle J, Stachowska-Pietka J, Öberg C, et al. ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: Classification, measurement, interpretation and rationale for intervention. Nephrologу and Dialуsis. 2023;25(2):232–266. EDN: UBXVHF doi: 10.28996/2618-9801-2023-232-266

[4] Морель И., Стаховска-Пьетка Д., Эберг К., и др. Рекомендации международного общества перитонеального диализа по оценке дисфункции перитонеальной мембраны у взрослых: классификация, методы оценки, интерпретация и обоснования для вмешательства // Нефрология и диализ. 2023. Т. 25, № 2. С. 232–266. EDN: UBXVHF doi: 10.28996/2618-9801-2023-232-266

[5] La Milia V, Di Filippo S, Crepaldi M, et al. Mini-peritoneal equilibration test: A simple and fast method to assess free water and small solute transport across the peritoneal membrane. Kidney Int. 2005;68(2):840–846. doi: 10.1111/j.1523-1755.2005.00465.x

[6] La Milia V., Di Filippo S., Crepaldi M., et al. Mini-peritoneal equilibration test: A simple and fast method to assess free water and small solute transport across the peritoneal membrane // Kidney Int. 2005. Vol. 68, N 2. P. 840–846. doi: 10.1111/j.1523-1755.2005.00465.x

[7] La Milia V, Limardo M, Virga G, et al. Simultaneous measurement of peritoneal glucose and free water osmotic conductances. Kidney Int. 2007;72(5):643–650. doi: 10.1038/sj.ki.5002405

[8] La Milia V., Limardo M., Virga G., et al. Simultaneous measurement of peritoneal glucose and free water osmotic conductances // Kidney Int. 2007. Vol. 72, N 5. P. 643–650. doi: 10.1038/sj.ki.5002405

[9] Gu J, Bai E, Ge C, et al. Peritoneal equilibration testing: Your questions answered. Perit Dial Int. 2023;43(5):361–373. doi: 10.1177/08968608221133629

[10] Gu J., Bai E., Ge C., et al. Peritoneal equilibration testing: Your questions answered // Perit Dial Int. 2023. Vol. 43, N 5. P. 361–373. doi: 10.1177/08968608221133629

[11] Clause AL, Keddar M, Crott R, et al. A large intraperitoneal residual volume hampers adequate volumetric assessment of osmotic conductance to glucose. Perit Dial Int. 2018;38(5):356–362. doi: 10.3747/pdi.2017.00219

[12] Clause A.L., Keddar M., Crott R., et al. A large intraperitoneal residual volume hampers adequate volumetric assessment of osmotic conductance to glucose // Perit Dial Int. 2018. Vol. 38, N 5. P. 356–362. doi: 10.3747/pdi.2017.00219

[13] Salikhova KA, Gerasimchuk RP, Sabodash AB, et al. Separated and combined fulfillment of the standard peritoneal equilibration test (PET) and mini-PET. Nephrology and dialysis. 2023;25(2):267–274. EDN: JJLKJR doi: 10.28996/2618-9801-2023-2-267-274

[14] Салихова К.А., Герасимчук Р.П., Сабодаш А.Б., и др. Раздельное и совмещенное проведение стандартного теста перитонеального равновесия (ПЭТ) и мини-ПЭТ // Нефрология и диализ. 2023. Т. 25, № 2. С. 267–274. EDN: JJLKJR doi: 10.28996/2618-9801-2023-2-267-274

[15] Zemchenkov AYu, Gerasimchiuk RP, Kostyleva TG. Dislocation of the peritoneal dialysis catheter. Nephrology and dialysis. 2007;9(2):168–172. EDN: IAWNFB

[16] Земченков А.Ю., Герасимчук Р.П., Костылева Т.Г. Дислокация перитонеального катетера // Нефрология и диализ. 2007. Т. 9, № 2. С. 168–172. EDN: IAWNFB

[17] Brown EA, Blake PG, Boudville N, et al. International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis. Perit Dial Int. 2020;40(3):244–253. doi: 10.1177/0896860819895364

[18] Brown E.A., Blake P.G., Boudville N., et al. International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis // Perit Dial Int. 2020. Vol. 40, N 3. P. 244–253. doi: 10.1177/0896860819895364

[19] Perl J, Brown EA, Chan CT, et al. Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023;103(5):842–858. doi: 10.1016/j.kint.2023.01.006

[20] Perl J., Brown E.A., Chan C.T., et al. Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference // Kidney Int. 2023. Vol. 103, N 5. P. 842–858. doi: 10.1016/j.kint.2023.01.006

[21] Ngamvichchukorn T, Ruengorn C, Noppakun K, et al. Association between pretransplant dialysis modality and kidney transplant outcomes: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(10):e2237580. doi: 10.1001/jamanetworkopen.2022.37580

[22] Ngamvichchukorn T., Ruengorn C., Noppakun K., et al. Association between pretransplant dialysis modality and kidney transplant outcomes: a systematic review and meta-analysis // JAMA Netw Open. 2022. Vol. 5, N 10. P. e2237580. doi: 10.1001/jamanetworkopen.2022.37580

[23] Liu R, Ye H, Peng Y, et al. Incremental peritoneal dialysis and survival outcomes: a propensity-matched cohort study. J Nephrol. 2023;36(7):1907–1919. doi: 10.1007/s40620-023-01735-4

[24] Liu R., Ye H., Peng Y., et al. Incremental peritoneal dialysis and survival outcomes: a propensity-matched cohort study // J Nephrol. 2023. Vol. 36, N 7. P. 1907–1919. doi: 10.1007/s40620-023-01735-4

[25] Albakr RB, Bargman JM. A comparison of hemodialysis and peritoneal dialysis in patients with cardiovascular disease. Cardiol Clin. 2021;39(3):447–453. doi: 10.1016/j.ccl.2021.04.013

[26] Albakr R.B., Bargman J.M. A comparison of hemodialysis and peritoneal dialysis in patients with cardiovascular disease // Cardiol Clin. 2021. Vol. 39, N 3. P. 447–453. doi: 10.1016/j.ccl.2021.04.013

[27] Ng CH, Ong ZH, Sran HK, Wee TB. Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis. Int Urol Nephrol. 2021;53(7):1363–1371. doi: 10.1007/s11255-020-02683-9

[28] Ng C.H., Ong Z.H., Sran H.K., Wee T.B. Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis // Int Urol Nephrol. 2021. Vol. 53, N 7. P. 1363–1371. doi: 10.1007/s11255-020-02683-9

[29] Kim SM, Kang BC, Kim HJ, et al. Comparison of hemodialysis and peritoneal dialysis patients’ dietary behaviors. BMC Nephrol. 2020;21(1):91. doi: 10.1186/s12882-020-01744-6

[30] Kim S.M., Kang B.C., Kim H.J., et al. Comparison of hemodialysis and peritoneal dialysis patients’ dietary behaviors // BMC Nephrol. 2020. Vol. 21, N 1. P. 91. doi: 10.1186/s12882-020-01744-6

[31] Heaf J, Heiro M, Petersons A, et al. First-year mortality in incident dialysis patients: results of the peridialysis study. BMC Nephrol. 2022;23(1):229. doi: 10.1186/s12882-022-02852-1

[32] Heaf J., Heiro M., Petersons A., et al. First-year mortality in incident dialysis patients: results of the peridialysis study // BMC Nephrol. 2022. Vol. 23, N 1. P. 229. doi: 10.1186/s12882-022-02852-1

[33] Cheng XBJ, Bargman J. Complications of peritoneal dialysis part II: nonmechanical complications. Clin J Am Soc Nephrol. 2024;19(6):791–799. doi: 10.2215/CJN.0000000000000418

[34] Cheng X.B.J., Bargman J. Complications of peritoneal dialysis part II: nonmechanical complications // Clin J Am Soc Nephrol. 2024. Vol. 19, N 6. P. 791–799. doi: 10.2215/CJN.0000000000000418

[35] Zhao H, Zhang HL, Jia L. High glucose dialysate-induced peritoneal fibrosis: Pathophysiology, underlying mechanisms and potential therapeutic strategies. Biomed Pharmacother. 2023;165:115246. doi: 10.1016/j.biopha.2023.115246

[36] Zhao H., Zhang H.L., Jia L. High glucose dialysate-induced peritoneal fibrosis: Pathophysiology, underlying mechanisms and potential therapeutic strategies // Biomed Pharmacother. 2023. Vol. 165. P. 115246. doi: 10.1016/j.biopha.2023.115246

[37] Kopytina V, Pascual-Antón L, Toggweiler N, et al. Steviol glycosides as an alternative osmotic agent for peritoneal dialysis fluid. Front Pharmacol. 2022;13:868374. doi: 10.3389/fphar.2022.868374

[38] Kopytina V., Pascual-Antón L., Toggweiler N., et al. Steviol glycosides as an alternative osmotic agent for peritoneal dialysis fluid // Front Pharmacol. 2022. Vol. 13. P. 868374. doi: 10.3389/fphar.2022.868374

[39] Li PK, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42(2):110–153. doi: 10.1177/08968608221080586

[40] Li P.K., Chow K.M., Cho Y., et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment // Perit Dial Int. 2022. Vol. 42, N 2. P. 110–153. doi: 10.1177/08968608221080586

RIGHTS & PERMISSIONS

Eco-Vector